ResearchMoz.us

ResearchMoz is the one stop online destination to find and buy market research reports and Industry Analysis. We fulfill all your research needs spanning across industry verticals with our huge collection of market research reports. We provide our services to all sizes of organizations and across all industry verticals and markets. Our Research Coordinators have in-depth knowledge of reports as well as publishers and will assist you in making an informed decision by giving you unbiased and deep insights on which reports will satisfy your needs at the best price.

Showing posts with label Product Pipeline. Show all posts
Showing posts with label Product Pipeline. Show all posts

Tuesday, 30 June 2015

E.ON SE - Power Plants and SWOT Analysis, Trend, Analysis, and Forecasts to 2015

Posted on 23:32 by Unknown
ResearchMoz.us include new market research report"E.ON SE - Power Plants and SWOT Analysis, 2015 Update " to its huge collection of research reports.

E.ON SE - Power Plants and SWOT Analysis, 2015 Update

Summary

The report contains a detailed description of the power generation companys business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), and major products and services.


Scope

- Major Power Plants (assets) - summarized and detailed information about the power plants (assets).
- Operational Metrics (capacity, generation, revenue, sales, number of consumers).
- Business description - A detailed description of the companys operations and business divisions.
- Corporate strategy - GlobalDatas summarization of the companys business strategy.
- SWOT analysis - A detailed analysis of the companys strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands
- Key employees - A list of the key executives and personnel heading key departments/functions.
- Executive biographies - A brief summary of the executives employment history.
- Financial deals - Coverage of key financial deals from 2006 onwards, depending upon information availability
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.

* Note: Some sections may be missing if data is unavailable for the company.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis, corporate strategy and major products and services are incorporated in the profile to assist in various business decisions (M&A and JV).
- Identify potential customers and suppliers with this reports analysis of the companys business structure, operations, major products and services and business strategy.


- Understand and respond to competitors business structure and strategies with GlobalDatas detailed SWOT analysis. In this, the companys core strengths, weaknesses, opportunities and threats are analyzed, providing an up to date objective view of the company.


For More Information Kindly Contact:
Email: sales@researchmoz.us 
Posted in , | No comments

Thursday, 11 June 2015

Merck & Co., Inc. - Product Pipeline Review - Industry Shares, Size, Trend, Analysis, and Forecasts to 2015

Posted on 03:24 by Unknown
ResearchMoz.us include new market research report"Merck & Co., Inc. - Product Pipeline Review - 2015 " to its huge collection of research reports.

Global Markets Directs, Merck & Co., Inc. Product Pipeline Review 2015, provides an overview of the Merck & Co., Inc.s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Merck & Co., Inc.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.


Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides brief overview of Merck & Co., Inc. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Merck & Co., Inc.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the Merck & Co., Inc.s pipeline products


Reasons to buy

Evaluate Merck & Co., Inc.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Merck & Co., Inc. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Merck & Co., Inc.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Merck & Co., Inc. and exploit collaboration and partnership opportunities
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Merck & Co., Inc.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Merck & Co., Inc. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues



For More Information Kindly Contact:
Email: sales@researchmoz.us 






Posted in , | No comments

Wednesday, 10 June 2015

Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review Size, Trend, Analysis, and Forecasts to 2015

Posted on 00:24 by Unknown
ResearchMoz.us include new market research report"Laboratorios Del Dr. Esteve S.A. - Product Pipeline Review - 2015 " to its huge collection of research reports.

Global Markets Directs, Laboratorios Del Dr. Esteve S.A. Product Pipeline Review 2015, provides an overview of the Laboratorios Del Dr. Esteve S.A.s pharmaceutical research and development focus.


This report provides comprehensive information on the current therapeutic developmental pipeline of Laboratorios Del Dr. Esteve S.A.s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Directs team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Scope

The report provides brief overview of Laboratorios Del Dr. Esteve S.A. including business description, key information and facts, and its locations and subsidiaries
The report reviews current pipeline of Laboratorios Del Dr. Esteve S.A.s human therapeutic division and enlists all their major and minor projects
The report features product description and descriptive mechanism of action for key pipeline products along with the products developmental history and major milestones 
Special feature on out-licensed and partnered product portfolio
The report summarizes all the dormant and discontinued pipeline projects
Latest company statement 
Latest news and deals relating to the Laboratorios Del Dr. Esteve S.A.s pipeline products


Reasons to buy

Evaluate Laboratorios Del Dr. Esteve S.A.s strategic position with total access to detailed information on its product pipeline
Assess the growth potential of Laboratorios Del Dr. Esteve S.A. in its therapy areas of focus
Identify new drug targets and therapeutic classes in the Laboratorios Del Dr. Esteve S.A.s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
Develop strategic initiatives by understanding the focus areas of Laboratorios Del Dr. Esteve S.A. and exploit collaboration and partnership opportunities

All Latest Market Research Report @ http://www.researchmoz.us/latest-report.html

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Plan mergers and acquisitions effectively by identifying the most promising pipeline of Laboratorios Del Dr. Esteve S.A.
Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Explore the dormant and discontinued projects of Laboratorios Del Dr. Esteve S.A. and identify potential opportunities in those areas
Avoid Intellectual Property Rights related issues













For More Information Kindly Contact:
Email: sales@researchmoz.us 
Posted in , | No comments
Subscribe to: Posts (Atom)